![]() |
市场调查报告书
商品编码
1684613
製药机械市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测Pharmaceuticals Machinery Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球製药机械市场价值为 252 亿美元,并有望大幅成长,预计 2025 年至 2034 年期间的复合年增长率为 6.4%。这一强劲的成长轨迹受到全球对医药产品需求不断增长的推动,人口老化、慢性病发病率不断上升以及个人化医疗的日益普及推动。製造技术的进步,加上仿製药和疫苗生产的加速,进一步扩大了市场的潜力。不断发展的生物製药产业专注于生物製剂、生物相似药和创新疗法,也需要最先进的机器,为製造商创造有利可图的机会。严格的监管要求必然需要先进的设备来确保精准度和合规性,而对製药合约製造组织(CMO)的日益依赖是加速市场扩张的重要因素。
目前,药品生产很大程度上依赖为满足特定需求而量身订製的尖端机械。生物製剂、疫苗和生物相似药的生产需要专门的设备,例如高精度填充系统和无菌加工机械,以维持最高的品质和安全标准。 CMO 和合约开发和製造组织 (CDMO) 正在投资先进技术,确保它们能够满足多家製药公司的大规模生产需求。此次合作进一步增强了产业能力,提高了生产效率和灵活性。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 252亿美元 |
预测值 | 464亿美元 |
复合年增长率 | 6.4% |
2024 年,固体剂量机领域将成为市场领导者,创收 96 亿美元。预计 2025 年至 2034 年期间的复合年增长率为 6.8%。固体剂型,包括片剂、胶囊和粉末,是製药业使用最广泛的剂型,需要高效率、自动化和高速的机械。製造商越来越重视客製化和法规遵循性,以满足特定的生产要求。此外,生物製剂和生物相似药产量的不断增长,也增加了对发酵槽、搅拌器和干燥器等专用设备的需求,这些设备对于将活性药物成分 (API) 转化为成品至关重要。
全自动操作模式在 2024 年占据了 61% 的市场份额,预计到 2034 年的复合年增长率为 6.6%。全自动机器简化了药品(包括药片、胶囊和注射)的高速生产流程,管理了填充、封盖、贴标和包装等关键功能。这些机器满足了生产对精度和效率日益增长的需求,确保了一致的品质并降低了错误率。半自动机器将自动化与人工监督相结合,为追求灵活性和效率的製造商提供了替代方案。
美国製药机械市场规模在 2024 年达到 57 亿美元,预计到 2034 年将以 6.5% 的复合年增长率成长。该地区的成长得益于对创新药物的需求不断增加、疫苗製造的进步以及对小批量和个人化药物生产的关注。人口老化和慢性病发病率上升导致的医疗保健需求不断增长,进一步凸显了市场的不断扩大。
The Global Pharmaceuticals Machinery Market was valued at USD 25.2 billion in 2024 and is poised for substantial growth, projected to expand at a CAGR of 6.4% between 2025 and 2034. This robust growth trajectory is fueled by the rising global demand for pharmaceutical products, driven by an aging population, the increasing prevalence of chronic diseases, and the growing adoption of personalized medicine. Advancements in manufacturing technologies, coupled with the accelerated production of generic drugs and vaccines, further amplify the market's potential. The evolving biopharmaceutical sector, with its focus on biologics, biosimilars, and innovative therapeutics, also demands state-of-the-art machinery, creating lucrative opportunities for manufacturers. Stringent regulatory requirements necessitate advanced equipment for precision and compliance, and the increasing reliance on pharmaceutical contract manufacturing organizations (CMOs) is an essential factor in accelerating market expansion.
Pharmaceutical production now relies heavily on cutting-edge machinery tailored to meet specific needs. The manufacturing of biologics, vaccines, and biosimilars requires specialized equipment, such as high-precision fill-finish systems and sterile processing machinery, to maintain the highest quality and safety standards. CMOs and contract development and manufacturing organizations (CDMOs) are investing in advanced technologies, ensuring they can meet large-scale production demands for multiple pharmaceutical companies. This collaboration further enhances the industry's capabilities, allowing for greater efficiency and flexibility in production.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $25.2 Billion |
Forecast Value | $46.4 Billion |
CAGR | 6.4% |
In 2024, the solid dosage machine segment emerged as the market leader, generating USD 9.6 billion. It is anticipated to grow at a CAGR of 6.8% between 2025 and 2034. Solid dosage forms, including tablets, capsules, and powders, are the most widely used in the pharmaceutical industry, necessitating highly efficient, automated, and high-speed machinery. Manufacturers increasingly prioritize customization and regulatory compliance to meet specific production requirements. Additionally, the growing production of biologics and biosimilars has increased the need for specialized equipment such as fermentation tanks, mixers, and dryers, critical in converting active pharmaceutical ingredients (APIs) into finished products.
The fully automatic operational mode accounted for 61% of the market share in 2024, with growth projected at a CAGR of 6.6% through 2034. Fully automatic machines streamline high-speed production processes for pharmaceuticals, including tablets, capsules, and injectables, managing critical functions such as filling, capping, labeling, and packaging. These machines address the rising demand for precision and efficiency in production, ensuring consistent quality and reduced error rates. Semi-automatic machines, blending automation with manual oversight, offer an alternative for manufacturers seeking flexibility and efficiency.
The US pharmaceuticals machinery market reached USD 5.7 billion in 2024 and is forecasted to grow at a CAGR of 6.5% through 2034. Growth in this region is driven by increasing demand for innovative drugs, advancements in vaccine manufacturing, and a focus on small-batch and personalized medicine production. Rising healthcare needs, fueled by an aging population and a higher prevalence of chronic conditions, further underscore the expanding market.